Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thirteen Principles For Conducting CER, According To United BioSource Exec

Executive Summary

During a recent DIA-sponsored conference, United BioSource Corp.’s Bryan Luce previewed a paper that will outline 13 principles that should be taken into account when developing comparative effectiveness research.

You may also be interested in...



People In The News – Tracking The Latest Industry Personnel Changes

PCORI completes its executive leadership team; new top executives at Sigma-Tau, Teva business units; BIO elects new chairman; more personnel announcements in this month’s column

CER Credibility Hinges On Having Criteria For Using Results In Medical Decisions – National Health Council

National Health Council President Weinberg calls for the development of criteria, with the involvement of patients and patient organizations, to measure the usability of comparative effectiveness research as a means of improving its credibility.

Additional Standards Needed To Make CER Meaningful And Adoptable, Case Study Shows

What started out as an exercise to show how comparative effectiveness research could be quickly adopted and help improve health outcomes ended up revealing that there remains a long way to go.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel